3629 results for «846»
3629 results
TAVI in aortic regurgitation and large annulus
20 May 2026 – From EuroPCR 2026
Focusing on TAVI in patients with aortic regurgitation and large annulus, this session reviews clinical outcomes and advancements including aneurysm progression slowing, device regurgitation assessment by cardiac MRI, one-year results with Ken-valve, novel retrievable self-expanding valves, staging classifications, and balloon-expandable valve performance.
AI in imaging & the cathlab - opportunities in procedural planning & guidance
20 May 2026 – From EuroPCR 2026
This session explores the role of artificial intelligence in imaging and the cathlab, emphasizing computer vision applications distinct from language models. It discusses AI's integration into procedural planning and guidance, balancing algorithmic support with physician judgement to enhance interventional cardiology workflows.
Coronary innovations and artificial intelligence: new devices, smarter tools, better outcomes
20 May 2026 – From EuroPCR 2026
This session provides a practical update on emerging coronary innovations and AI technologies, including next-generation calcium modification devices, bioresorbable scaffolds, sirolimus drug-coated balloons, and AI-driven coronary physiology and imaging tools. It offers a roadmap for integrating these advancements into clinical practice, addressing technology selection, reimbursement, training,...
Calcified coronary: LIVE Educational Case from Clinique Pasteur - Toulouse, France
20 May 2026 – From EuroPCR 2026
This live educational case from Clinique Pasteur in Toulouse, France, showcases the management of complex calcified coronary lesions through multimodality imaging guidance. It addresses the selection of plaque modification devices and discusses optimal stenting strategies for challenging calcified bifurcation lesions, complemented by live procedural insights and...
Tricuspid interventions: find the best candidate
20 May 2026 – From EuroPCR 2026
This session reviews the phenotypes of tricuspid regurgitation and their diagnostic pathways, emphasizing standardized and pragmatic diagnostic steps. It also addresses criteria for identifying optimal timing and candidates for tricuspid valve interventions.
New TAVI platforms - Novel devices, early data
20 May 2026 – From EuroPCR 2026
Explore the latest developments in TAVI technology, featuring novel valve platforms and early clinical data. The session covers outcomes from new self-expandable and balloon-expandable valves, innovative single-operator techniques, redo TAVI approaches, and advances in CT sizing powered by deep learning.
Complications during left main PCI: how to manage and how to avoid
20 May 2026 – From EuroPCR 2026
This session addresses the identification, prevention, and management of complications arising during left main percutaneous coronary intervention (PCI). Through detailed case presentations and analyses, it highlights anatomical and procedural risk factors, strategies to anticipate and recognize complications such as stent deformation and coronary perforation, and effective...
Imaging the calcified lesions: what you need to see
20 May 2026 – From EuroPCR 2026
This session emphasizes critical imaging aspects necessary for assessing calcified coronary lesions. It addresses lesion-specific Agatston scoring, OCT-guided PCI optimization, coronary CT planning, histopathological insights, and predictors of stent underexpansion after calcium modification.
Bleeding and thrombotic risk in LAA closure patients
20 May 2026 – From EuroPCR 2026
This session provides a thorough examination of bleeding and thrombotic risks in patients undergoing left atrial appendage (LAA) closure. It reviews risk factors for device-related thrombosis, compares anticoagulation strategies post-procedure, and presents real-world clinical outcomes, particularly in high bleeding risk populations and special groups such as...
Major Late-Breaking Trials from EuroPCR 2026
20 May 2026 – From EuroPCR 2026
This session presents major late-breaking trials from EuroPCR 2026, reviewing contemporary evidence on coronary revascularization in TAVI patients, long-term outcomes of PCI versus CABG for left main disease, and comparative effectiveness of LAA closure versus NOAC in atrial fibrillation across age groups, with clinical practice implications.
Optimising bifurcation PCI: learning from randomised controlled trials
20 May 2026 – From EuroPCR 2026
This session delves into optimizing bifurcation PCI by examining contemporary European practices and outcomes from multiple randomized controlled trials. Key topics include multivessel TALENT trial results, 30-day outcomes of left main PCI with sirolimus-eluting stents from the NAGOMI COMPLEX study, comparative insights from the CROSS-LCX Registry...
Transcatheter mitral interventions: outcomes and new procedural approaches
20 May 2026 – From EuroPCR 2026
This session covers transcatheter mitral interventions, comparing surgical and transcatheter approaches, including TEER and TMVR. It presents clinical outcomes, safety data, and innovative procedural techniques such as transeptal BATMAN to prevent left ventricular outflow tract obstruction during TMVR.
Challenging TAVI access: exploring transfemoral boundaries and mastering alternative access
20 May 2026 – From EuroPCR 2026
This session investigates the boundaries of transfemoral access for TAVI and strategies to safely extend its use. It also provides a comprehensive review of facilitated transfemoral TAVI techniques and explores alternative access options, offering critical insights for managing challenging TAVI cases.
TAVI procedural complications - Part 5: vascular complications, coronary issues and more
20 May 2026 – From EuroPCR 2026
This session addresses procedural complications during TAVI, focusing on vascular complications, coronary issues, and rare device-related events. It includes case analyses of aortic dissection, valve infolding, stent dislodgement, and management strategies for complex anatomical challenges.
Lost, crushed, fractured: stent complications in real life
20 May 2026 – From EuroPCR 2026
This session addresses real-world challenges of stent complications including loss, crushing, and fracture during PCI. Through case-based discussions, it explores complex scenarios such as stent dislodgement, embolisation, and management strategies when initial plans evolve into complicated realities.
Tackling calcified lesions with IVUS guidance and optimisation
20 May 2026 – From EuroPCR 2026
This session delves into the critical role of Intravascular Ultrasound (IVUS) in characterizing and managing calcified coronary lesions. Attendees can explore an imaging-guided approach to calcium treatment, including case presentations that demonstrate stent selection and procedural optimization. Emphasis is placed on applying imaging-based optimization metrics to...
Navigating the complexity of high bleeding risk
20 May 2026 – From EuroPCR 2026
Focusing on patients with high bleeding risk undergoing PCI, this session presents contemporary evidence on prevalence, procedural strategies with different stent types, antiplatelet therapy considerations including diabetic and sex-specific outcomes, and novel technologies such as sirolimus-coated balloons and machine learning models for restenosis prediction.
Transcatheter rescue in cardiogenic shock
20 May 2026 – From EuroPCR 2026
This session presents cutting-edge transcatheter rescue interventions in cardiogenic shock scenarios. It covers emergent valve-in-valve procedures, hybrid approaches for valvular heart disease with heart failure, management of ventricular septal rupture post-myocardial infarction, and percutaneous closure techniques for high-risk patients, emphasizing lifesaving interventional strategies.
Complications in CAD PCI
20 May 2026 – From EuroPCR 2026
This session focuses on the recognition and management of complications during coronary artery disease PCI. It includes cases of acute guide catheter crises, rare post-PCI chest pain etiologies, innovative stent retrieval techniques, and critical procedural challenges, providing an educational journey through complex complication management.
Insight from recent evidence in coronary artery disease: value of DCB for de novo lesions (SELUTION) and imaging for left main PCI (OPTIMAL)
21 May 2026 – From EuroPCR 2026
This session reviews pivotal recent evidence impacting daily practice in coronary artery disease management. It discusses the role of drug-coated balloons (DCB) for de novo lesions as evaluated in the SELUTION trial and evaluates intracoronary imaging strategies for left main PCI as presented in the OPTIMAL...